Cyp3A gene expression in human gut epithelium

Pharmacogenetics

Volumn 4, Issue 5, 1994, Pages 247-259

  Kolars, Joseph C ^a   Lown, Kenneth S ^a   Schmiedlin Ren, Phyllissa ^a   Ghosh, Mita ^a   Fang, Che ^a   Wrighton, Steven A ^b   Merion, Robert M ^a   Watkins, Paul B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; MESSENGER RNA; PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; INTESTINE EPITHELIUM; LIVER CELL; MICROSOME; NORTHERN BLOTTING; ORGAN DONOR; PANCREAS DUCT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH; TISSUE DISTRIBUTION; XENOBIOTIC METABOLISM;

ADULT; BASE SEQUENCE; BLOTTING, WESTERN; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINE, SMALL; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028063131     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199410000-00003     Document Type: Article

References (49)

1. Aoyama T, Yamano S, Waxman DJ, et al. Cytochrome P-450 hPCN3, a novel cytochrome P-450IIIA gene product that is differentially expressed in adult human liver, cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCNl and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 1989: 264, 10388-10395.
2. Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin Bl. Proc Natl Acad Sci USA 1990: 87, 4790-793.
3. Bargetzi MJ, Aoyama T, Gonzalez FJ, Meyer UA. Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. Clin Pharmacol Ther 1989: 46, 521-527.
4. Beaune P, Kremers P, Letawe-Goujon F, Gielen JE. Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 1985: 34, 3547-3552.
5. Bonkovsky HL, Hauri HP, Marti U, Gasser R, Meyer UA. Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phénobarbital. Gastroenterology 1985: 88, 458-467.
6. Bork RW, Muto T, Beaune PH, Srivastava PK, Lloyd RS, Guen- gerich FP. Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. J Biol Chem 1989: 264, 910-919.
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987: 162, 156-159.
8. Combalbert J, Fabre I, Fabre G, et al. Metabolism of cyclosporin A: IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab Dispos 1989: 17, 197-207.
9. de Waziers I, Cugnenc PH, Yang CS, Leroux J-P, Beaune PH. Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 1989: 253, No. 1: 387-394.
10. Gonzalez FJ, Schmid BJ, Umeno M, et al. Human P450PCN1: Sequence, chromosome localization, and evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 1988: 7, 79-86.
11. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 1986a: 261, 5051-5060.
12. Guengerich FP, Meuller-Enoch D, Blair IA. Oxidation of quinidine by human liver cytochrome P-450. Mol Pharmacol 1986b: 30, 287-295.
13. Guengerich FP. Characterization of human microsomal cytochrome P-450 enzymes. Annu Rev Pharmacol Toxicol 1989: 29, 241-264.
14. Hebert MF, Roberts JP, Prueksaritanont T, Benet LZ. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin Pharmacol 1992: 52, 453-457.
15. Jacolot F, Simon I, Dreano Y, Beaune P, Riche C, Berthou F. Identification of the cytochrome P450IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem Pharmacol 1991: 41, 1911-1919.
16. Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y. Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem Pharmacol 1987: 36, 453-456.
17. Kolars JC, Awni WM, Merion RM, Watkins PB. First-pass metabolism of cyclosporin by the gut. Lancet 1991: 338, 1488-1490.
18. Kolars JC, Schmiedlin-Ren P, Dobbins WO III, Schuetz J, Wrighton SA, Watkins PB. Heterogeneity of cytochrome P-450IIIA expression in rat gut epithelia. Gastroenterology 1992a: 102, 1186-1198.
19. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.J Clin Invest 1992b: 90, 1871-1878.
20. Kolars JC, Lown KS, Schmeidlin-Ren P, Watkins PB. Aflatoxin B1-adduct formation in small bowel enterocytes of rat and man. Gastorenterology 1994: 106(2), 433-439.
21. Komori M, Nishio K, Ohi H, Kitada M, Kamataki T. Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. J Biochem (Tokyo) 1989: 105, 161-163.
22. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450111 gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988: 43, 630-635.
23. Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 1989: 36, 89-96.
24. Lipkin M. Proliferation and differentiation of normal and diseased gastrointestinal cells. In: Leonard R. Johnson, ed. Physiology of the Gastrointestinal Tract. New York: Raven Press, 1987: 255-284.
25. Marchuk D., Drumm M, Saulino A, Collins FS. Construction of T-vectors: A rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 1991: 19, 1154.
26. McKinnon RA, Burgess WM, Gonzalez FJ, McManus ME. Metabolic differences in colon mucosal cells. Mutation Res 1993: 290, 27-33.
27. Miranda AL, Reed RL, Guengerich FP, Buhler DR. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver. Carcinogenesis 1991: 12(3), 515-519.
28. Molowa DT, Schuetz EG, Wrighton SA, et al. Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc Natl Acad Sci USA 1986: 83, 5311-5315.
29. Murray GI, Barnes TS, Sewell HF, Ewen SW, Melvin WT, Burke MD. The immunocytochemical localization and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. Br J Clin Pharmacol 1988: 25, 465-475.
30. Nelson DR, Kamataki T, Waxman DJ, et al. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 1993: 12, 1-51.
31. Pichard L, Fabre I, Fabre G, et al. Cyclosporin A drug interactions: Screening for inducers and inhibitors of cytochrome P450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990: 18, 595-606.
32. Ratanasavanh D, Beaune P, Morel F, Flinois JP, Guengerich FP, Guillouzo A. Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991: 13, 1142-1151.
33. Regina RW, Kari PH, Lu AYH, Thomas PE, Guengerich FP, Vyas KP. Biotransformation of Lovastatin. Arch Biochem Biophys 1991: 290, 355-361.
34. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 1977: 74, 5463-5467.
35. Schacterle GR, Pollack RL. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 1973: 51, 654-655.
36. Schuetz JD, Beach DL, Guzelian PS. Selective expression of cytochrome P450CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 1994: in press.
37. Shimada T, Guengerich FP. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci USA 1989: 86, 462-465.
38. Shimada T, Martin MV, Pruess-Schwartz D, Marnett LJ, Guengerich FP. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8- dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res 1989: 49, 6304-6312.
39. Tjia JF, Webber IR, Back DJ. Cyclosporin metabolism by the gastrointestinal mucosa. Br J Clin Pharmacol 1993: 31, 344-346.
40. van der Hoeven TA, Coon MJ. Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J Biol Chem 1974: 249, 6302-6310.
41. Vickers AEM, Fisher V, Connors S, et al. Cyclosporin A metabolism in human liver, kidney, and intestine slices comparison to rat and dog slices and human cell lines. Drug Metab Dispos 1993: 20, 802-809.
42. Watkins PB. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin Liver Dis 1990: 10, 235-250.
43. Watkins PB, Wrighton SA, Maurel P, et al. Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci USA 1985: 82, 6310-6314.
44. Watkins PB, Wrighton SA, Schuetz EG, Molowa DT, Guzelian PS. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J Clin Invest 1987: 80, 1029-1036.
45. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. J Clin Invest 1989: 83, 688-697.
46. Weber IR, Peters WHM, Back DJ. Cyclosporin metabolism by human gastrointestinal mucosal microsomes. Br J Clin Pharmacol 1992: 33, 661-664.
47. Wrighton SA, Ring BJ, Watkins PB, Vandenbranden M. Identification of a polymorphically expressed member of the human cytochrome P-450III family. Mol Pharmacol 1989: 36, 97-105.
48. Wrighton SA, Brian WR, Sari MA, et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol 1990: 38, 207-213.
49. Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 1992: 22, 1-21.